Isometric training
Pick it for a named goal, as an add-on to heavy dynamic lifting, not a replacement: wall squats or handgrip lower resting blood pressure (the best evidence, in non-athletes), near-maximal holds stiffen tendons, long-length or explosive holds build size or rapid force in untrained people; for tendon pain holds are a tolerable load, not a reliable painkiller, and calf holds for running economy are plausible, not proven
The decision this framework makes
Whether an isometric — an overcoming push or pull against something that cannot move, or a yielding hold of a load that is trying to move the joint — is the right tool for a named goal, and if so at what effort, hold length, angle, volume and frequency; and what not to promise, so that holds are used where they work and do not displace the heavy dynamic lifting that carries the endurance-performance evidence.
Key Findings — what isometric training has and has not been shown to do
Resting blood pressure is the best-supported use, measured in non-athletes. Across 270 RCTs (15,827 adults), isometric training lowered resting BP by 8.24/4.00 mmHg against no exercise and ranked first of five modes for systolic pressure (SUCRA 98.3%), 3.86 mmHg more than aerobic training; by sub-mode the wall squat −10.47/−5.33 and handgrip −7.10/−3.46 mmHg, a gap the network could not separate (3.24 mmHg, −3.38 to 9.83).
The isometric part is 19 of the 270 trials and 24 effect sizes (wall squat 4, handgrip 17) with no head-to-head comparison, and reductions were larger at higher baseline pressure (REF-1150, A-).
In 24 RCTs of adults with high-normal BP or grade 1 hypertension, office BP fell 6.97/3.86 mmHg with no rise in adverse events (risk ratio 1.12), but every trial was at high risk of bias and certainty is very low to low (REF-1151, A-).
Tendons stiffen when the tendon is strained hard, in whatever contraction. Across 61 studies (763 mostly untrained people) loading raised tendon stiffness (SMD 0.74), mainly by changing the material; protocols reaching about 5% strain did best (SMD 1.04) but on 3 training groups, and contraction mode made no clear difference (REF-1152, A-).
In 11 adults, 14 weeks of isometric calf contractions stiffened the Achilles only in the leg loaded at 90% MVC (+36.0%), not at 55% (+7.9%, not significant) (REF-1153, B). At 70% MVC, 20-s holds stiffened the knee-extensor tendon where 1-s pulses at matched volume did not, with the same strength (+33.9% vs +31.8%) (REF-1154, B, n = 8).
The two concurrent strength-plus-aerobic groups in REF-1152 showed no stiffness change, so endurance athletes may see less (transfer).
Running economy: plausible, not proven. The 90% MVC calf programme (5 × 4 × 3 s, 14 weeks) was followed by about 4% lower running cost in 26 male runners (REF-1155, B, randomisation not stated) and again in recreational runners (10.6 → 10.2 W/kg within the trained group, not significant against controls, 13 of 36 dropped out; REF-1156, B).
The one meta-analysis that pooled isometric studies found a non-significant effect (ES −0.269, 95% CI −0.79 to 0.252; 3 studies, 28 vs 27 runners) and did not include the replication (REF-801, A-). Heavy dynamic lifting holds the stronger economy evidence (SYNTH-44).
Isometrics train specifically. Knee holds at 65 degrees for 4 weeks raised strength 12% there, 11% and 7% at the neighbouring tested angles and nothing at 95 degrees (REF-1159, B+, n = 22 untrained men).
Sustained 3-s holds at 75% raised maximal strength 23% and quadriceps volume 8.1%; 1-s "fast and hard" contractions raised maximal strength 17% and alone improved force in the first 50-100 ms (+34% at 50 ms, +17% at 100 ms) (REF-1161, B+, untrained men).
Long-length holds grew muscle faster in 3 studies (1.16 vs 0.47%/week), an edge that nearly vanished pooled over 9 (REF-1158, A-) and that a Bayesian meta-analysis of 12 trials did not find (SMD 0.05-0.09; REF-1168, A-).
Holds are not a reliable painkiller for tendon pain. Across 10 small RCTs isometrics were not superior to isotonic exercise for pain, straight after a session or up to 12 weeks (REF-1149, A-).
In a pre-registered crossover of 21 patients, pain fell a small 0.9 of 10 after 5 × 45 s at 70% MVIC and after leg extensions alike (0.8 and 1.1), and the fall was no longer significant 45 min later (REF-1147, B+); heavy calf holds gave no relief in Achilles tendinopathy (4.2 → 4.9 of 10, not significant; REF-1148, B).
So it is the size of the 7.0-to-0.17 result in 6 volleyball players that did not replicate (REF-627, B), not the existence of some small relief; the one positive in-season RCT may share its cohort with a null one (REF-1145, B+; REF-1146, B).
Pushing and holding are not interchangeable (thin). In 10 adults, pushing at 70% MVC raised concentric (g 0.31) and eccentric (g 0.50) torque, holding did not, but holding grew the quadriceps more (g 0.46) (REF-1163, B). Holding an elbow position at 80% MVC stayed still 19.1 s against 41.4 s when pushing (REF-1164, B, n = 10, elbow extensors only).
Default (what to prescribe first)
Name the goal before the exercise. An isometric is chosen for one of the rows below; "isometrics in general" has no outcome attached (the base's practice).
For an endurance athlete with gym access, heavy dynamic lifting stays the strength default (SYNTH-43 B+, SYNTH-44 B+); isometrics are added for a tendon, blood pressure, a weak angle, a testing need, or a block where lifting does not fit — not swapped in for the lifting (practice; REF-1158, A-, tested no endurance outcome).
Default form: overcoming — push or pull against something that cannot move (a bar under pins, a strap, a wall). It is the form used in the tendon, economy, angle, rapid-force and testing trials (REF-1153, REF-1155, REF-1159, REF-1161, REF-1166); yielding holds are a second option with thinner evidence (row below).
Decision (goal → what to do)
| Goal | What to do | Source and how sure |
|---|---|---|
| Stiffer tendons; Achilles and patellar tendon health (healthy tendon) | Overcoming, near-maximal: about 90% MVC, 3-s contractions with 3 s off, 4 per set × 5 sets, 3-4×/week for 14 weeks (the calf programme; joint angle not reported in the entries). At about 70% MVC choose long holds (4 × 20 s, 1 min rest, 4×/week, 12 weeks) over 1-s pulses. Judge after 8 weeks or more and keep it going (practice); heavy dynamic work is an equal route | REF-1152 A- (stiffness SMD 0.74; ~5% strain SMD 1.04 on 3 groups; no contraction-mode difference; changes showed between 4 and 8 weeks); REF-1153 B (+36.0% at 90% vs +7.9% at 55% MVC, n = 11, abstract); REF-1154 B (n = 8, abstract); REF-517 A (intensity, not contraction type); mostly untrained adults — TRANSFER |
| Running economy | Optional add-on, not the main gym work: the 90% MVC calf programme above on top of running and of heavy lifting; expect at most about 4% at easy pace; plausible, not proven. Cyclists: no entry | REF-1155 B (~4%, 26 men, randomisation not stated, abstract); REF-1156 B (10.6 → 10.2 W/kg within the trained group, not significant against controls); REF-801 A- (pooled ES −0.269, CI −0.79 to 0.252, not significant); REF-1157 B (maximal 3 × 3 × 3 s, 2×/week, 6 weeks: 2.4-km time better than a circuit, P = .002; economy edge not significant, the circuit group improved too); REF-1144 B+ (isometric calf raises inside a heavy-plus-jumps programme; fresh economy unchanged) |
| Maximal strength | Heavy dynamic lifting first (SYNTH-43, SYNTH-44). If isometric: 80-100% MVC, 1-5 s per contraction, 30-90 s of contraction a session, at several angles or the target one (a narrative dose); in one trial 40 sustained 3-s holds at 75% per leg, 3×/week for 12 weeks, gave +23% | REF-1160 C+ (narrative, abstract); REF-1161 B+ (untrained men, knee extension on a dynamometer); REF-1158 A- (across studies intensity explained little of the maximal-force gain — conflicts with the 80-100% rule); gains were measured isometrically — TRANSFER to dynamic and race performance untested |
| Rate of force development, explosive | Ballistic intent: from rest, "as fast and hard as possible" to at least 80% MVC for about 1 s; 4 × 10 per leg, 5 s between, 3×/week, 12 weeks. Keep these apart from sustained maximal holds (the base's reading of an interference result) | REF-1161 B+ (+34% at 50 ms, +17% at 100 ms, explosive group only, with 7% of the high-load time); REF-1158 A- (ballistic beat ramped for rapid force); REF-1159 B+ (mixed in one session: no early-force gain); untrained men — TRANSFER |
| Sprint peak power (track sprinters) | Maximal on-bike pushes against a locked flywheel, seated in the race position: 3-s efforts at 45, 90 and 135 degrees from top dead centre, each leg leading, 60 s between efforts and 2 min between sets, building from 1 × 3 to 4 × 4 per angle and lead leg over 6 weeks on 2-3 gym days a week, in place of the heaviest lift (a lighter fast squat was kept). Elite sprinters in an off-season strength phase only; for road and endurance riders, or as an off-bike leg-press hold at a pedal angle, it is untested (inference) | REF-1182 B (24 elite track sprinters, coach-allocated, not randomised: power per kilogram +4.3% vs −0.5%, interaction p = 0.02; absolute power +2.9%, not different from controls, p = 0.14; cycling-specific isometric torque +12.5%, p = 0.002; knee-extensor strength and muscle architecture no between-group differences); REF-1159 B+ (angle specificity: why several angles) |
| Hypertrophy (long muscle length) | Sustained holds at long length (knee flexed beyond 70 degrees): 70-75% MVC, 3-30 s holds, more than 80-150 s of contraction a session, prescribed for more than 36 sessions (a narrative dose). Fragile: treat long length as "at least as good", not better; mainly for a joint that tolerates a held angle but not loaded movement (practice) | REF-1158 A- (1.16 vs 0.47%/week on 3 studies; 0.88 vs 0.61 and ES 0.046 vs 0.045 on 9); REF-1168 A- (SMD 0.05-0.09, trivial); REF-1162 B+ (long-length holds vs full-range lifting −0.20 cm, 95% HDI −0.54 to 0.16, 23 trained lifters, 6 weeks); REF-1160 C+; REF-1161 B+ (sustained +8.1% vs explosive +2.6%, not significant) |
| Joint-angle-specific weak point | Hold at or near the angle that fails; expect the gain to spread to neighbouring angles and more toward the shorter-muscle side; for general strength use several angles. The trial dose: 3 × 10 explosive plus 3 × 6 maximal 3-s holds at 65 degrees of knee flexion, 14 sessions in 4 weeks | REF-1159 B+ (+12% at 65°, +11% at 50°, +7% at 80°, +5% at 35°, none at 95°; group × angle P = 0.029; 22 untrained men); REF-1158 A- (long-length holds spread to more angles); REF-1160 C+ (the authors' suggested use) |
| Tendon pain (patellar, Achilles) | A tolerable way to keep loading a painful tendon inside a progressive plan — not a painkiller and not a promise. If tried: 5 × 45 s at 70% MVIC, 2 min apart; keep it if that athlete's pain settles, drop it if it flares (practice); long-term capacity comes from heavy slow resistance or eccentric loading over about 12 weeks; training continues under the pain-monitoring rule of SYNTH-73 | REF-1149 A- (10 RCTs, 294 people: not superior, p = 0.19); REF-1147 B+ (0.9 of 10, same as dynamic, no longer significant at 45 min; 4 of 20 responders); REF-1148 B (Achilles: no relief, the most painful worsened); REF-1145 B+ (the one positive in-season RCT, about 1 of 10 more, abstract; possibly the same cohort as REF-1146); REF-1146 B (4 weeks, no difference); REF-627 B (its size not replicated); REF-626 A- (heavy slow resistance = eccentric at 12 and 52 weeks); REF-628 B+ |
| Resting blood pressure | Overcoming holds, 4 × 2 min with 1-4 min rest, 3×/week, kept up for weeks (mean 9.8 weeks): handgrip at about 30% MVC, or a wall squat at a depth that makes the fourth hold hard (RPE about 8-9 of 10). An add-on to aerobic training and to the physician's plan, never a replacement; with raised BP, clear it with the physician first and do not hold the breath (practice) | REF-1150 A- (−8.24/−4.00 mmHg; wall squat −10.47, handgrip −7.10 systolic; wall squat vs handgrip not significant; 4 and 17 effect sizes); REF-1151 A- (−6.97/−3.86 mmHg in raised BP; adverse events risk ratio 1.12; certainty very low to low; 24-h systolic not significant); general population, larger effects with higher baseline — a normotensive athlete should expect less (TRANSFER) |
| In-season or low-fatigue maintenance | Practice, not evidence: when heavy lifting cannot fit (a heavy race block, travel, a joint that dislikes loaded movement), short maximal or explosive holds keep a strength stimulus; go back to heavy dynamic lifting when possible. The tested in-season dose is one heavy dynamic session a week (well-trained cyclists, SYNTH-43); stretching it to 10 days is practice | REF-1160 C+ (the authors suggest this use and claim less fatigue than dynamic training; abstract); REF-1161 B+ (explosive: 7% of the high-load time, +17% vs +23% maximal strength; untrained); no isometric maintenance trial in the base; SYNTH-43 and SYNTH-44 for the dynamic dose |
| Warm-up before explosive efforts | For jump-type efforts only: after a general warm-up, 2-3 maximal pushes of about 3-5 s (8-12 s of contraction in total) at a shallow squat angle (knee 90-140 degrees), then 4-8 min before the effort (the base's practice built on moderator signals); try it in training first. Untested for sprint finishes, time-trial starts or endurance races | REF-1165 A- (jump ES 0.35 vs no primer, no different from a heavy dynamic set; no significant effect on strength or power, few studies; GRADE low; the prediction interval includes no effect); REF-688 A (an older pool: maximal isometric conditioning −0.09); endurance warm-up: REF-270 B, REF-273 B+ |
| Testing maximal strength | Isometric mid-thigh pull on a fixed bar, the same position every time, one familiarisation; treat a change under about 5% as noise and trust only clearly larger ones (the base's reading of the CVs; a smallest detectable change of about 8.5% has been cited); track absolute force and body mass separately. A proxy of strength, not a 1RM, and not a way to set loads | REF-1166 B+ (16 studies: median ICC 0.96, CV 4.9%, range 0.7-11.1%; relative force median ICC 0.88; the ~8.5% figure is cited there from REF-1167's introduction; mostly team-sport athletes); REF-1167 B+ (r 0.705-0.970 with 1RM squat; correlational; no endurance data); REF-147 B+ (a cyclist trial measured strength as a maximal isometric half squat) |
| Yielding vs overcoming | Overcoming for strength that shows in movement, for testing and for the tendon and economy programmes. Yielding (holding a load in place: a loaded wall sit, a held split squat) may grow muscle more, and in an elbow study it broke down sooner — setting shorter holds or a lower effort than for pushing is the base's inference. A first signal only | REF-1163 B (70% MVC, 20 s, 4-6 reps, knee 80°, 12 sessions in 6 weeks, n = 10: pushing raised concentric g 0.31 and eccentric g 0.50; holding grew rectus femoris more, g 1.44; tendon thickness g 0.12, trivial); REF-1164 B (19.1 vs 41.4 s still, 50.0 vs 58.8 s in total, elbow extensors at 80% MVC, n = 10); REF-1165 A- (both forms worked as primers) |
| HYROX (wall balls, sled, carries) | No entry tests isometric training for any HYROX station. House practice, labelled: the stations are muscular endurance under lactate, so train them dynamically and after running (SYNTH-71); use isometrics only for the rows above — a tendon, blood pressure, a low-fatigue strength touch in race weeks, the mid-thigh pull as a strength check | No entry — practice; station demands: REF-510 B (lactate and RPE peaked at wall balls; sled push 128 s, sled pull 155 s); SYNTH-71 |
Practical Application
What NOT to do
Limitations
How this entry was checked and changed
(blood pressure on two A- meta-analyses of general-population and hypertensive adults; tendon stiffness on an A meta-analysis, an A- meta-analysis whose strain contrast rests on three training groups, and two B within-subject trials; running economy on two B trials from one laboratory against a non-significant A- pool; tendon pain on an A- review of 10 small RCTs and a B+ pre-registered crossover, neither showing holds better than isotonic exercise for pain (one B+ in-season RCT was positive, possibly sharing a cohort with a null one); size, angle and rapid force on an A- systematic review without meta-analysis and B+/B trials of 8-43 mostly untrained or recreational adults; warm-up on an A- review and testing on two B+ reviews in team-sport and strength athletes; yielding vs overcoming on two B studies of 10 people; on-bike sprint power on one B non-randomised trial in 24 elite track sprinters; the doses for endurance athletes, the in-season use and every HYROX line are practice)